Medtide Inc. (HKG:3880)
Hong Kong
· Delayed Price · Currency is HKD 21.80
+0.62 (2.93%)
Apr 29, 2026, 3:59 PM HKT
Medtide Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 570.09 | 442.23 | 336.77 | 350.84 | 282.14 |
| Revenue Growth (YoY) | 28.91% | 31.31% | -4.01% | 24.35% | - |
| Cost of Revenue | 208.48 | 193.24 | 157.28 | 150.05 | 121.44 |
| Gross Profit | 361.61 | 248.98 | 179.5 | 200.79 | 160.69 |
| Selling, General & Admin | 120.16 | 115.9 | 71.84 | 65.72 | 57.88 |
| Research & Development | 29.05 | 27.96 | 22.47 | 20.74 | 17.34 |
| Operating Expenses | 150.6 | 144.77 | 94.91 | 87.59 | 77.08 |
| Operating Income | 211.01 | 104.21 | 84.59 | 113.2 | 83.61 |
| Interest Expense | -1.24 | -1.14 | -0.22 | -1.28 | -4.44 |
| Interest & Investment Income | 24.54 | 13.56 | 6.92 | 0.91 | 0.34 |
| Currency Exchange Gain (Loss) | - | 7.31 | 5.07 | 11.94 | -2.54 |
| Other Non Operating Income (Expenses) | 16.05 | -48.35 | -41.8 | -65.53 | -20.34 |
| EBT Excluding Unusual Items | 250.37 | 75.59 | 54.55 | 59.25 | 56.63 |
| Gain (Loss) on Sale of Investments | 0.37 | 3.09 | 7.59 | 7.92 | 0.45 |
| Gain (Loss) on Sale of Assets | - | -0.23 | -0.16 | 0.38 | 32.31 |
| Pretax Income | 250.75 | 78.45 | 61.98 | 67.56 | 89.39 |
| Income Tax Expense | 33.37 | 19.28 | 13.07 | 13.58 | 9.11 |
| Net Income | 217.37 | 59.17 | 48.91 | 53.98 | 80.28 |
| Net Income to Common | 217.37 | 59.17 | 48.91 | 53.98 | 80.28 |
| Net Income Growth | 267.35% | 21.00% | -9.40% | -32.76% | - |
| Shares Outstanding (Basic) | 134 | 125 | 125 | 100 | 74 |
| Shares Outstanding (Diluted) | 134 | 128 | 125 | 100 | 92 |
| Shares Change (YoY) | 3.96% | 2.74% | 24.41% | 8.83% | - |
| EPS (Basic) | 1.63 | 0.47 | 0.39 | 0.54 | 1.09 |
| EPS (Diluted) | 1.63 | 0.38 | 0.39 | 0.54 | 1.06 |
| EPS Growth | 332.06% | -3.38% | -27.41% | -49.19% | - |
| Free Cash Flow | - | 99.49 | 33.15 | 42.65 | 96.49 |
| Free Cash Flow Per Share | - | 0.78 | 0.27 | 0.42 | 1.04 |
| Gross Margin | 63.43% | 56.30% | 53.30% | 57.23% | 56.96% |
| Operating Margin | 37.01% | 23.57% | 25.12% | 32.27% | 29.64% |
| Profit Margin | 38.13% | 13.38% | 14.52% | 15.39% | 28.45% |
| Free Cash Flow Margin | - | 22.50% | 9.84% | 12.16% | 34.20% |
| EBITDA | 237.67 | 130.86 | 110.66 | 135.56 | 106.21 |
| EBITDA Margin | 41.69% | 29.59% | 32.86% | 38.64% | 37.64% |
| D&A For EBITDA | 26.65 | 26.65 | 26.07 | 22.35 | 22.59 |
| EBIT | 211.01 | 104.21 | 84.59 | 113.2 | 83.61 |
| EBIT Margin | 37.01% | 23.57% | 25.12% | 32.27% | 29.64% |
| Effective Tax Rate | 13.31% | 24.57% | 21.09% | 20.10% | 10.20% |
Source: S&P Capital IQ. Standard template. Financial Sources.